Navigation Links
Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis

NEWPORT NEWS, Va., June 9 /PRNewswire/ -- A group of surgeons from Legacy Good Samaritan Hospital (Portland, Oregon) have found Breast-Specific Gamma Imaging (BSGI) has a significant value in the pre-operative assessment for the extent of breast cancer in patients with known diagnosis. The findings were presented at The Society of Black Academic Surgeons Annual meeting held in Cleveland, Ohio.

BSGI is a molecular breast imaging technique used for the early detection of breast cancer and in the differentiation of malignant and benign tumors. It relies on advanced gamma imaging technology and mammographic positioning to optimize results. For this study BSGI was conducted with a commercially available high-resolution gamma camera, the Dilon 6800.

The study evaluated 138 patients with a cancer diagnosis. In this group, additional disease was found in a total of 11 percent of patients. Six percent were in the same breast and 5 percent were in the opposite breast. This finding is very similar to that of an MRI study conducted by Bilimoria from Northwestern University; however, BSGI provided a significantly lower false positive rate of 7 percent compared to 78 percent with the MRI study.

Member of the Legacy Good Samaritan Hospital group of surgeons, Dr. M. Zhou, concluded that BSGI parallels MRI in sensitivity in the preoperative setting, demonstrates better specificity than MRI, and is less expensive than MRI.

About Dilon Technologies

Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; Northwestern Memorial Hospital, Chicago; and The Rose, Houston. For more information on Dilon Technologies please visit

M. Zhou MD, N. Johnson MD, S. Gruner MD, G.W. Ecklund MD, P. Meunier MD, S. Bryn RN, G. Green MD. Clinical Utility of Breast Specific Gamma Imaging For Evaluating Disease Extent in the Newly Diagnosed Breast Cancer Patient. SBAS 18th Annual Scientific Session, Cleveland, OH, April 18, 2008.

SOURCE Dilon Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
2. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
3. Gilbert Hospital Continues Cutting Edge Treatments
4. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
5. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
6. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
7. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
8. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
9. Hospital to Hold MRSA Briefing for Media and Community Leaders
10. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
11. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
Post Your Comments:
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
Breaking Medicine News(10 mins):